Detalhe da pesquisa
1.
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol
; 23(10): 1495-1506, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151395
2.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(11): 1556, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582823
3.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(3): 326-336, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778252
4.
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
Immunity
; 54(3): 571-585.e6, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497609
5.
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Nature
; 595(7866): 309-314, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953401
6.
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
Nature
; 565(7737): 43-48, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559380
7.
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature
; 547(7664): 413-418, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28723893
8.
WHIMP links the actin nucleation machinery to Src-family kinase signaling during protrusion and motility.
PLoS Genet
; 16(3): e1008694, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196488